Nonsyndromic cleft lip with cleft palate
Hematocrit
Eosinophil counts
Plateletcrit
Core binding factor acute myeloid leukemia
Mean corpuscular volume
Monocyte percentage of white cells
White blood cell count
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)
High light scatter reticulocyte count
Sum neutrophil eosinophil counts
Granulocyte count
High light scatter reticulocyte percentage of red cells
Post bronchodilator FEV1
C-reactive protein levels or total cholesterol levels (pleiotropy)
C-reactive protein levels or LDL-cholesterol levels (pleiotropy)
C-reactive protein levels or triglyceride levels (pleiotropy)
Estrogen receptor status in HER2 negative breast cancer
Estrogen receptor status in breast cancer
Response to antidepressants and depression
QT interval (sulfonylurea treatment interaction)
JT interval (sulfonylurea treatment interaction)
Reticulocyte count
Systolic blood pressure
Childhood ear infection
Hypothyroidism
Mean corpuscular hemoglobin
Palmitoleic acid (16:1n-7) levels
Gondoic acid (20:1n-9) levels
LDL cholesterol levels
Total cholesterol levels
Triglyceride levels
Protein C levels
Atrial fibrillation
Attention deficit hyperactivity disorder symptom score
Prostate-specific antigen levels (conditioned on lead SNPs)
Myopia
Male-pattern baldness
Myeloid white cell count
Red blood cell count
Lymphocyte count
Immature fraction of reticulocytes
Neutrophil count
Resting heart rate
Left atrial antero-posterior diameter
Attention deficit hyperactivity disorder
Response to alcohol consumption (flushing response)
Prudent dietary pattern
Western dietary pattern
Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)
Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Hemoglobin levels
Platelet count
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
Granulocyte percentage of myeloid white cells
Sum eosinophil basophil counts
Monobrow
Monocyte count
Lymphocyte percentage of white cells
Age-related disease endophenotypes
Age-related diseases, mortality and associated endophenotypes
Gallstone disease
Crohn's disease
Inflammatory bowel disease
Interleukin-2 receptor antagonist levels
Interleukin-4 levels
Interleukin-17 levels
Monocyte chemoattractant protein-1 levels
Macrophage inflammatory protein 1a levels
Platelet-derived growth factor BB levels
Stem cell factor levels
Body mass index
Motion sickness
Hippocampal atrophy
Gout
Metabolite levels
Hypertriglyceridemia
Thyroid volume
Glycemic traits
Sex hormone-binding globulin levels
Fasting blood insulin (BMI interaction)
Fasting blood glucose
Fasting blood insulin
PR interval in Tripanosoma cruzi seropositivity
Fasting blood glucose (BMI interaction)
Systemic sclerosis
Breast cancer
Pyoderma gangrenosum in inflammatory bowel disease
Response to zileuton treatment in asthma (FEV1 change interaction)
Epilepsy and lamotrigine-induced maculopapular eruptions
Serum alpha1-antitrypsin levels
Schizophrenia
Pediatric autoimmune diseases
Type 2 diabetes
Cerebrospinal fluid t-tau:AB1-42 ratio
Cerebrospinal T-tau levels
Alzheimer disease and age of onset
Post bronchodilator FEV1/FVC ratio
Proteinuria and chronic kidney disease
3-hydroxypropylmercapturic acid levels in smokers
Emphysema imaging phenotypes
LDL cholesterol
HDL cholesterol
Triglycerides
Cholesterol, total
Blood metabolite levels
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)
circulating leptin levels adjusted for BMI
circulating leptin levels
Tuberculosis
Waist-to-hip ratio adjusted for body mass index
Glomerular filtration rate in non diabetics (creatinine)
Glomerular filtration rate (creatinine)
Carotid intima media thickness
Plasma lactate levels
Corticobasal degeneration
Homeostasis model assessment of insulin resistance
Homeostasis model assessment of beta-cell function
Lipoprotein-associated phospholipase A2 activity and mass
Metabolic traits
Waist circumference and related phenotypes
Type 1 diabetes
Electrocardiographic traits
Glycated hemoglobin levels
Calcium levels
Two-hour glucose challenge
Fasting plasma glucose
Uric acid levels
Hematological parameters
Cognitive performance
Cardiovascular disease risk factors
Urate levels
Hematological and biochemical traits
Femoral neck bone geometry
Breast cancer (male)
Multiple sclerosis
Disc degeneration (lumbar)
Non-albumin protein levels
Breast size
Acute lymphoblastic leukemia (childhood)
Adiponectin levels
Liver enzyme levels (gamma-glutamyl transferase)
Dental caries
Triglycerides-Blood Pressure (TG-BP)
Waist Circumference - Triglycerides (WC-TG)
Hemoglobin
Height
Diabetic retinopathy
Information processing speed
Alzheimer's disease (late onset)
Chronic kidney disease
C-reactive protein levels
Thyroid hormone levels
Obesity-related traits
Polycystic ovary syndrome
Palmitic acid (16:0) levels
Visceral fat
Pulmonary function decline
PR interval
Femoral neck bone mineral density
Breast cancer in BRCA2 mutation carriers
Metabolic syndrome
Paget's disease
Lipid traits
Asthma
HIV-1 susceptibility
Metabolite levels (Dihydroxy docosatrienoic acid)
C-reactive protein
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)
Leukocyte telomere length
Eosinophil percentage of white cells
Hemoglobin concentration
Mean platelet volume
Carotid intima media thickness x smoking interaction
Morningness
FEV1
Tourette syndrome
Mean corpuscular hemoglobin concentration
Lung function (FVC)
Menstruation quality of life impact (dysmenorrhea)
General cognitive ability
Waist circumference adjusted for body mass index
Anti-chlamydia trachomatis IgG seropositivity
Basophil count
Spherical equivalent or myopia (age of diagnosis)
Myopia (age of diagnosis)
Adolescent idiopathic scoliosis
Reaction time
Intelligence
Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)
Alcohol consumption
Thyroid stimulating hormone levels
Ketonuria
Ketonuria (moderate to severe)
Ketonuria (mild)
Protein quantitative trait loci (liver)
Acceptance of an invitation to participate in a mental health questionnaire
Pure non-grapefruit juice consumption
Bitter beverage consumption
Coffee consumption
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)
Bitter alcoholic beverage consumption
Cortical thickness (MOSTest)
Brain morphology (min-P)
Subcortical volume (MOSTest)
Urolithiasis
Brain morphology (MOSTest)
Hypertension
Cortical surface area (MOSTest)
Subcortical volume (min-P)
Arrhythmia
Low density lipoprotein cholesterol levels
Iron status biomarkers (ferritin levels)
Severe depressive disorders in coronary artery disease
Osteoarthritis of the hip or knee
Coronary artery disease and triglyceride levels (multivariate analysis)
Hemoglobin A1c levels
High density lipoprotein cholesterol levels
Red cell distribution width
Problematic alcohol use (MTAG)
Alcohol consumption (drinks per week) (MTAG)
Autism spectrum disorder
Platelet distribution width
Nonalcoholic steatohepatitis
Serum metabolite levels
Liver fat content (MRI proton density fat fraction measure)
Bipolar disorder (MTAG)
Schizophrenia (MTAG)
Fasting triglyceride levels
Postprandial triglyceride levels
Reticulocyte fraction of red cells
Electrocardiographic traits (multivariate)
Problematic alcohol use
Serum interleukin-6 concentration in active individuals
Deep white matter hyperintensities
Gestational insulin sensitivity
Alanine aminotransferase levels
Aspartate aminotransferase levels
Factor VII activity
Factor VII activity or levels
Serum alkaline phosphatase levels
Cortical volume
Prostate cancer
Kidney cancer
Cancer (pleiotropy)
Walking pace
Estradiol levels
Bioavailable testosterone levels
Nucleus accumbens volume change rate x age interaction (2df)
Cancer (pleiotropy)(bidirectional)
Sex hormone-binding globulin levels adjusted for BMI
Glucose homeostasis traits
Longevity (90 years and older)
Age-related cataracts (age at onset)
Menarche (age at onset)
Blood pressure (smoking interaction)
Response to antidepressant treatment (citalopram)
Glycemic traits (pregnancy)
Staphylococcus aureus infection
Vitamin D levels
Plasma amyloid beta peptide concentrations (ABx-42)
Breast cancer (early onset)
Rheumatoid arthritis
Serum total protein levels
Serum albumin levels
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)
QT interval
Red blood cell traits
PR segment duration
Magnesium levels
Polychlorinated biphenyl levels
Schizophrenia (treatment resistant)
Lipid metabolism phenotypes
Asymmetrical dimethylarginine levels
Coffee consumption (cups per day)
Urate levels in overweight individuals
Urate levels in obese individuals
Sitting height ratio
Hip circumference adjusted for BMI
Heart rate response to recovery post exercise (30 sec)
Heart rate response to recovery post exercise (10 sec)
Heart rate response to recovery post exercise (40 sec)
Heart rate response to recovery post exercise (50 sec)
Heart rate response to recovery post exercise (20 sec)
Pursuit maintenance gain
Systolic blood pressure (cigarette smoking interaction)
Renal cell carcinoma
Testicular germ cell tumor
Autism spectrum disorder or schizophrenia
BMI (adjusted for smoking behaviour)
Diastolic blood pressure
Neuroticism
Renal underexcretion gout
Renal overload gout
Pulse pressure
Venous thromboembolism adjusted for sickle cell variant rs77121243-T
Body fat percentage
Sum basophil neutrophil counts
Myringotomy
Scarlet fever
Lung cancer in ever smokers
Daytime nap
Peripheral arterial disease (traffic-related air pollution interaction)
Nonalcoholic fatty liver disease
Alcohol consumption in current drinkers
Depressive symptoms
Lung adenocarcinoma
Chronic sinus infection
Waist-hip ratio
Mosquito bite size
Body mass index (joint analysis main effects and smoking interaction)
Perceived unattractiveness to mosquitoes
BMI in non-smokers
Facial morphology (factor 14, intercanthal width)
Facial morphology (factor 22)
White blood cell count (monocyte)
Alcohol consumption (drinks per week)
Diastolic blood pressure (cigarette smoking interaction)
Major depression and alcohol dependence
Glomerular filtration rate
Systemic lupus erythematosus
Blood protein levels
Gamma glutamyl transferase levels
Alanine transaminase levels
Lactate dehydrogenase levels
Experiencing mood swings
Psoriasis
Serum metabolite concentrations in chronic kidney disease
Serum bilirubin levels in metabolic syndrome
QRS duration
Possible neuropathic pain in post total joint replacement surgery for osteoarthritis
Major depressive disorder
Total body bone mineral density
Iris color (a* coordinate)
Iris color (b* coordinate)
Branched-chain amino acid levels (Isoleucine)
Branched-chain amino acid levels (Leucine)
Branched-chain amino acid levels (Valine)
High altitude adaptation
Heel bone mineral density
P wave duration
Serum uric acid levels in response to allopurinol in gout
Asthma (childhood onset)
Depression in response to interferon-based therapy in chronic hepatitis C
Insulin levels adjusted for BMI
Ratio of the area under the curve for insulin and the area under the curve for glucose
Area under the curve of insulin levels
Incremental insulin
Corrected insulin response
Corrected insulin response adjusted for insulin sensitivity index
Estimated glomerular filtration rate in non-diabetics
Estimated glomerular filtration rate
Parental longevity (combined parental attained age, Martingale residuals)
Mean arterial pressure x alcohol consumption interaction (2df test)
Medial orbital frontal cortex volume
Lateral orbital frontal cortex volume
Pars orbitalis volume
Pars triangularis volume
Systolic blood pressure x alcohol consumption interaction (2df test)
Superior frontal gyrus volume
Superior parietal cortex volume
Corpus callosum mid-anterior volume
Familial squamous cell lung carcinoma
Basal cell carcinoma
Diastolic blood pressure x alcohol consumption interaction (2df test)
Proliferative diabetic retinopathy (vs no DR)
HDL cholesterol levels
Mental health study participation (completed survey)
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
Mean arterial pressure
HDL cholesterol levels in current drinkers
Triglyceride levels in current drinkers
Benign prostatic hyperplasia and lower urinary tract symptoms
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)
LDL cholesterol levels in current drinkers
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
Waist-to-hip ratio adjusted for BMI
Balding type 1
Keratinocyte cancer (MTAG)
Educational attainment (years of education)
Blood urea nitrogen levels
Body mass index (joint analysis main effects and physical activity interaction)
Body mass index in physically active individuals
Cognitive ability
Cognitive ability (MTAG)
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)
Bone fracture in osteoporosis
Alopecia areata
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
Overall survival in osteosarcoma
Sulfasalazine-induced agranulocytosis
Creatine kinase levels
Change in glucose in response to thiazide diuretic treatment in hypertension
Potassium levels
Chloride levels
Creatinine levels
Serum uric acid levels
Blood sugar levels
Offspring birth weight
Urinary sodium excretion
Non-lobar intracerebral hemorrhage (MTAG)
Sensorimotor dexterity
Predicted visceral adipose tissue
Cognitive performance (MTAG)
Self-reported math ability (MTAG)
Highest math class taken (MTAG)
Waist-to-hip ratio adjusted for BMI (additive genetic model)
Latent autoimmune diabetes vs. type 2 diabetes
Metabolic syndrome (multivariate analysis)
Birth weight
Educational attainment (MTAG)
Self-reported math ability
Breast cancer specific mortality in breast cancer
Age-related hearing impairment
Triglyceride to HDL cholesterol ratio
Lung function (FEV1) and waist to hip ratio adjusted for BMI
Lung function (FEV1) and waist circumference adjusted for BMI
Insulin-like growth factor 1 levels
Complement factor H-related protein 3 levels
Serum phosphate levels
Age at menopause
Testosterone levels
Total bilirubin levels
Bipolar I disorder
Urea levels
hemolysis of donated blood (osmotic)
Response to antipsychotic treatment in schizophrenia
Fasting glucose
Two-hour glucose
Fasting insulin
Serum urate levels
Externalizing behaviour (multivariate analysis)
Apolipoprotein A1 levels
Cystatin C levels
Apolipoprotein B levels
Depressive symptoms x stressful life events interaction (2df test)
Lung function (FEV1)
Bilirubin levels
Blood glucose levels
Mean sphered cell volume
Clear cell renal cell carcinoma
Mitochondrial DNA copy number
Fructosamine levels
Insulin levels
Cortical thickness
Alcohol consumption x experiences in childhood (felt loved by family member) interaction
Smoking x traumatic event in childhood (sexually molested) interaction
Cortical surface area
Hyperlipidemia
Lymphocyte-to-monocyte ratio
Cardiorespiratory fitness (vo2 max)
Childhood gender nonconformity
Corneal resistance factor (MTAG)
Aspartate aminotransferase to alanine aminotransferase ratio
Colorectal cancer
Direct bilirubin levels
Non-melanoma skin cancer
Cancer
Liver enzyme levels (alanine transaminase)
Liver enzyme levels (alkaline phosphatase)
Heel bone mineral density x serum urate levels interaction
Age at first birth
Femur bone mineral density x serum urate levels interaction
Low testosterone levels
Liver volume
Percent liver fat
COVID-19 (covid vs negative)
Fat-free mass
Uveal melanoma
Disease severity in uveal melanoma (TNM stage 3 or 4 vs TNM stage 1 or 2)
Mosaic loss of chromosome Y (Y chromosome dosage)
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
Brown vs. black hair color
Bipolar disorder
Microalbuminuria
Urinary albumin-to-creatinine ratio in diabetes
Childhood obesity
Urinary albumin-to-creatinine ratio
Peripheral artery disease
Adventurousness
Abdominal aortic calcification levels
Blond vs. brown/black hair color
Brain region volumes
Heel bone mineral density (MTAG)
Total body bone mineral density (MTAG)
Relative protein intake
Ebbinghaus illusion (overestimation)
TPE interval (resting)
OTU97_100 (Ruminococcaceae) abundance
C_Actinobacteria abundance
OTU97_354 (Alloprevotella) abundance
Cholesterol
Non-oily fish consumption
Refractive error
Lung function (FEV1/FVC)
OTU99_19 (Bacteria) prevalence
Cardiovascular disease
P_Actinobacteria abundance
Urinary metabolite levels in chronic kidney disease
OTU97_19 (Bacteria) prevalence
OTU99_39 (Alphaproteobacteria) prevalence
Gout (combined type)
Autoimmune traits
Intrinsic epigenetic age acceleration
Blood protein levels in cardiovascular risk
Cervical cancer
Cervical cancer (MTAG)
Hair color
Appendicular lean mass
Serum metabolite levels (CMS)
Birth length (MTAG)
Birth weight (MTAG)
Triglyceride levels x short total sleep time interaction (2df test)
Triglyceride levels x long total sleep time interaction (2df test)
Circulating leptin levels or fasting insulin levels
Circulating leptin levels or HOMA-IR
Circulating leptin levels or type 2 diabetes
Bone mineral density (hip) and hip bone size
Hip bone size
Cerebrospinal fluid sTREM-2 levels
HDL cholesterol levels x long total sleep time interaction (2df test)
Kidney stones
Morning person
HDL cholesterol levels x short total sleep time interaction (2df test)
Putamen volume
Alcohol consumption (drinkers vs non-drinkers)
Intraocular pressure
Age at loss of ambulation in Duchenne muscular dystrophy
Alcohol consumption (heavy vs. light/non-drinkers)
Serum 25-Hydroxyvitamin D levels
Midgestational total 25-hydroxyvitamin D levels (maternal genetic effect)
Alcohol-associated liver disease in non drinkers
Glycemic traits (multi-trait analysis)
Plasma free amino acid levels (adjusted for twenty other PFAAs)
Plasma free amino acid levels
Proportion of activated microglia (inferior temporal cortex)
Leisure sedentary behaviour (computer use)
Triglycerides x physical activity interaction (2df test)
HDL cholesterol x physical activity interaction (2df test)
Response to norepinephrine-dopamine reuptake inhibitors (responders vs non-responders)
Depressed affect
Worry
Total testosterone levels
Hand grip strength
Hip shape (DXA scan)
Positive affect
Life satisfaction
Venous thromboembolism
Type 2 diabetes (adjusted for BMI)
Diverticular disease
Telomere length
Systolic blood pressure (baseline)
DSG4/FABP9 protein level ratio
DOK2/PDLIM7 protein level ratio
ENO2/MGLL protein level ratio
SCARA5/TGFBI protein level ratio
EGF/MGLL protein level ratio
FLT3/FLT3LG protein level ratio
FLT4/ICAM2 protein level ratio
FIS1/MGLL protein level ratio
PFKFB2/RILP protein level ratio
PFKFB2/SERPINB1 protein level ratio
PFKFB2/SRP14 protein level ratio
PMVK/PRDX5 protein level ratio
PMVK/PRTFDC1 protein level ratio
PMVK/PTPN6 protein level ratio
PMVK/TARBP2 protein level ratio
PMVK/TBCB protein level ratio
PODXL2/SEZ6L protein level ratio
PLAUR/PRSS8 protein level ratio
AMBP/EFEMP1 protein level ratio
ERP44/PFKFB2 protein level ratio
FST/FSTL3 protein level ratio
FURIN/IGSF3 protein level ratio
FURIN/PLA2G15 protein level ratio
CD58/ERBB3 protein level ratio
HPCAL1/PMVK protein level ratio
HSPA1A/MGLL protein level ratio
AHCY/FABP5 protein level ratio
High myopia
CANT1/ROR1 protein level ratio
ART3/RGMA protein level ratio
ATOX1/GYS1 protein level ratio
CDKN2D/PMVK protein level ratio
Low myopia vs hyperopia
Alcohol use disorder (consumption score)
DFFA/PMVK protein level ratio
DKK1/MGLL protein level ratio
ERBB2/FURIN protein level ratio
CASP8/PFKFB2 protein level ratio
APOM/MCAM protein level ratio
FBP1/SIGLEC7 protein level ratio
FGF21/LEP protein level ratio
FGFR2/TGFBR2 protein level ratio
FGR/NCF2 protein level ratio
GYS1/PPP1R2 protein level ratio
GYS1/STK11 protein level ratio
GYS1/USP8 protein level ratio
GYS1/WASF1 protein level ratio
NCF2/S100A11 protein level ratio
DAPP1/MGLL protein level ratio
DAPP1/PMVK protein level ratio
EFNA1/PIK3IP1 protein level ratio
EFNA1/TNFRSF1A protein level ratio
FABP1/RBP5 protein level ratio
FABP1/SULT2A1 protein level ratio
FABP4/FGF21 protein level ratio
FABP5/NSFL1C protein level ratio
FABP5/PDCD5 protein level ratio
FABP5/PEBP1 protein level ratio
FABP5/PPCDC protein level ratio
FABP5/TMSB10 protein level ratio
F7/VASN protein level ratio
FABP1/FABP2 protein level ratio
FABP1/HNMT protein level ratio
FABP1/LGALS4 protein level ratio
FABP1/RBP2 protein level ratio
FADD/MGLL protein level ratio
CCN2/MGLL protein level ratio
CD99/CD99L2 protein level ratio
TGFBI/VASN protein level ratio
DAG1/MGLL protein level ratio
ANXA3/PFKFB2 protein level ratio
GGH/INHBC protein level ratio
GGT1/MME protein level ratio
ACAA1/GRPEL1 protein level ratio
AHSP/BLVRB protein level ratio
Hyperopia
Smoking initiation (ever regular vs never regular) (MTAG)
Alcohol use disorder
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)
Urinary sodium to creatinine ratio
Gout vs asymptomatic hyperuricemia
Serum levels of protein FABP1
Serum levels of protein GFRAL
Serum levels of protein GAA
Childhood body mass index
Hodgkin's lymphoma
Depression
Unilateral cleft lip and palate
Unilateral cleft lip
Bilateral cleft lip and palate
Cognitive aspects of educational attainment
Oral glucose tolerance test-0h in pregnancy
Daily alcohol intake in rs671 GG genotype
Alcohol drinking status in rs671 GG genotype
Daily alcohol intake
Alcohol drinking status (ever drinker vs never drinker)
Daily alcohol intake in rs671 GA genotype
Alcohol drinking status in rs671 GA genotype
Daily alcohol intake x rs671 interaction (2df)
Alcohol drinking status x rs671 interaction (2df)
Apolipoprotein C-II levels
Apolipoprotein C-III levels
Household income (MTAG)
Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis
Breast cancer (estrogen-receptor positive)
Breast cancer (progesterone-receptor positive)
Ocular sarcoidosis
Autoimmune thyroid disease
Chronotype (sMEQ score)
Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
Trauma exposure in major depressive disorder
Central corneal thickness
Total triglycerides levels
Gut microbiota (bacterial taxa, hurdle binary method)
Trauma exposure
Mean spheric corpuscular volume
Caffeine consumption from coffee or tea
Mean reticulocyte volume
Neutrophil percentage of white cells
L-selectin levels
Deliberate self-harm
Parkinson's disease progression (cognitive)
Parental lifespan
Rectal cancer
Fasting triglycerides levels in small VLDL
Fasting mean diameter of VLDLD particles
Fasting triglycerides in VLDL
Fasting serum total triglycerides
Fasting triglycerides levels in small HDL
Postprandial phospholipid levels in medium VLDL
Postprandial triglycerides levels in medium VLDL
Postprandial free cholesterol in medium VLDL
Postprandial total lipids in medium VLDL
Postprandial medium VLDL particle concentration
Postprandial triglycerides in VLDL
Postprandial triglycerides levels in small VLDL
Postprandial phospholipid levels in small HDL
Postprandial serum total triglycerides
Postprandial mean diameter of VLDLD particles
Diastolic blood pressure (MTAG)
Fasting isoleucine
Systolic blood pressure (MTAG)
Hearing function (2 kHz)
Fasting total lipids in medium VLDL
Fasting medium VLDL particle concentration
Fasting phospholipid levels in medium VLDL
Fasting triglycerides levels in medium VLDL
Fasting free cholesterol in medium VLDL
Metabolic biomarkers (multivariate analysis)
Seropositivity (peptide co-occurrence module 12: H. pylori, for phages))
Platelet count at delivery
Postprandial isoleucine
Postprandial leucine
Postprandial triglycerides levels in medium HDL
Atrial fibrillation (MTAG)
Stroke (MTAG)
Familial combined hyperlipidemia defined by Consensus criteria
Familial combined hyperlipidemia defined by Mexico criteria
Thyroid stimulating hormone levels within normal range in pregnancy
Dyslipidemia
Decaffeinated coffee consumption and/or insomnia
Severe autoimmune type 2 diabetes
Brain vascular stenosis
Skeletal muscle mass
Thyroid cancer
Educational attainment
Cystatin C plasma levels
Anxiety
Familial combined hyperlipidemia defined by Dutch criteria
Familial combined hyperlipidemia defined by Brunzell criteria
Familial combined hyperlipidemia defined by Goldstein criteria
Dementia
Electrocardiogram morphology (amplitude at temporal datapoints)
Alcohol use disorder (total score)
Alcohol use disorder (dependence and problematic use scores)
Adult body size
Uterine fibroids
Diastolic blood pressure (baseline)
Pelvic organ prolapse
BRCA1/2-negative high-risk breast cancer
Metabolically unhealthy in normal weight
Facial wrinkles
DNA methylation variation (age effect)
Coronary artery disease in type 1 diabetes
Medication use (agents acting on the renin-angiotensin system)
Medication use (calcium channel blockers)
Medication use (thyroid preparations)
Fasting blood insulin adjusted for BMI
Fasting blood glucose adjusted for BMI
Lipid traits (pleiotropy) (HIPO component 2)
Clostridium difficile infection in multiple myeloma
Diffusing capacity of carbon monoxide
Cholesterol efflux capacity
Glycemic traits (pleiotropy)
Medication use (diuretics)
Medication use (drugs used in diabetes)
Medication use (beta blocking agents)
Medication use (HMG CoA reductase inhibitors)
wg rh intensity-contrast frontalpole
wg rh intensity-contrast supramarginal
Macular thickness
wg rh intensity-contrast parsorbitalis
wg rh intensity-contrast middletemporal
wg rh intensity-contrast parahippocampal
wg rh intensity-contrast superiorfrontal
HippSubfield lh volume subiculum-head
wg rh intensity-contrast rostralanteriorcingulate
wg lh intensity-contrast lateralorbitofrontal
wg lh intensity-contrast middletemporal
wg rh intensity-contrast lateralorbitofrontal
wg lh intensity-contrast parstriangularis
wg lh intensity-contrast rostralmiddlefrontal
wg lh intensity-contrast parsopercularis
Ischemic stroke in dyslipidemia
Insulin levels in lean individuals
Alanine transaminase levels in high alcohol intake
Chitinase-3-like protein 1 levels
Body mass index and LDL-C (pairwise)
Body mass index and triglycerides (pairwise)
Obstructive sleep apnea trait (minimum oxyhemoglobin saturation across sleep episode)
Age-related hearing impairment (MTAG)
Adipsin levels in type 2 diabetes
Follistatin levels
Cathepsin D levels
Kawasaki disease
HOMA-B (corrected for HOMA-IR)
CLEC1A/GPR37 protein level ratio
CLEC1B/MGLL protein level ratio
IGFBP1/IGFBP2 protein level ratio
IGFBP4/OGN protein level ratio
IL6ST/LEPR protein level ratio
B4GALT1/LRP11 protein level ratio
AZU1/MPO protein level ratio
ITIH3/VCAM1 protein level ratio
LAMP3/PRSS8 protein level ratio
LRP11/NECTIN2 protein level ratio
LRP11/ROR1 protein level ratio
LEPR/NRCAM protein level ratio
LEPR/NTRK2 protein level ratio
CNTN1/EGFR protein level ratio
CLSTN2/MATN2 protein level ratio
COMP/TGFBI protein level ratio
MANF/PMVK protein level ratio
CRADD/PMVK protein level ratio
CREG1/PLA2G15 protein level ratio
CRKL/MGLL protein level ratio
MGLL/PTPN6 protein level ratio
MGLL/SHMT1 protein level ratio
MGLL/SKAP2 protein level ratio
MGLL/STK4 protein level ratio
MGLL/VTA1 protein level ratio
MNDA/NCF2 protein level ratio
MME/NT5E protein level ratio
METAP2/PFKFB2 protein level ratio
MGLL/MITD1 protein level ratio
MGLL/MPIG6B protein level ratio
MGLL/PDLIM7 protein level ratio
MGLL/PLA2G4A protein level ratio
CST3/RARRES2 protein level ratio
CTSF/SMPD1 protein level ratio
CXCL3/MGLL protein level ratio
CTSD/PRCP protein level ratio
Pre-treatment viral load in HIV-1 infection
Percent glycated albumin
Low HDL-cholesterol levels
Strabismus
Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)
Epithelial ovarian cancer
Progressive supranuclear palsy
Iris heterochromicity
Body size at age 10
Obesity (extreme)
Macular telangiectasia type 2
Glycated hemoglobin HbA1c levels
Oral glucose tolerance test-2h
Oral glucose tolerance test-0h
Handedness (left-handed vs. right-handed)
Hemoglobin A1c (HbA1c, maximum, inv-norm transformed)
hemoglobin (minimum, inv-norm transformed)
hemoglobin (mean, inv-norm transformed)
height (minimum, inv-normal transformed)
hemoglobin (maximum, inv-norm transformed)
low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed)
height (mean, inv-normal transformed)
Hemoglobin A1c (HbA1c, mean, inv-norm transformed)
Hemoglobin A1c (HbA1c, minimum, inv-norm transformed)
What is your height? (cm, inv-normal transformed)
Alanine transaminase (ALT, maximum, inv-norm transformed)
Albumin (mean, inv-norm transformed)
Albumin (minimum, inv-norm transformed)
lymphocyte (absolute count, mean, inv-norm transformed)
lymphocyte (absolute count, maximum, inv-norm transformed)
Alanine transaminase (ALT, mean, inv-norm transformed)
Alanine transaminase (ALT, minimum, inv-norm transformed)
Aspartate aminotransferase (AST, maximum, inv-norm transformed)
Aspartate aminotransferase (AST, minimum, inv-norm transformed)
Aspartate aminotransferase (AST, mean, inv-norm transformed)
PT international normalized ratio (INR, minimum, inv-norm transformed)
low density lipoprotein cholesterol (LDLC, maximum, inv-norm transformed)
Albumin (maximum, inv-norm transformed)
mean corpuscular volume (MCV, mean, inv-norm transformed)
Abnormal spermatozoa (PheCode 609.2)
Chronic liver disease and cirrhosis (PheCode 571)
Abnormal results of function study of liver (PheCode 573.7)
Other chronic nonalcoholic liver disease (PheCode 571.5)
Unspecified diffuse connective tissue disease (PheCode 709.7)
Calculus of kidney (PheCode 594.1)
Concussion (PheCode 817)
mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)
mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)
mean corpuscular volume (MCV, maximum, inv-norm transformed)
mean corpuscular volume (MCV, minimum, inv-norm transformed)
Peritoneal or intestinal adhesions (PheCode 560.3)
platelet count (minimum, inv-norm transformed)
heart rate (HR, mean, inv-normal transformed)
Intestinal disaccharidase deficiencies and disaccharide malabsorption (PheCode 271.3)
Disorders of carbohydrate transport and metabolism (PheCode 271)
Other nutritional deficiency (PheCode 263)
Hyperglyceridemia (PheCode 272.12)
platelet count (mean, inv-norm transformed)
heart rate (HR, maximum, inv-normal transformed)
Type 2 diabetes (PheCode 250.2)
Impaired fasting glucose (PheCode 250.41)
Diabetes mellitus (PheCode 250)
Other abnormal glucose (PheCode 250.42)
Abnormal glucose (PheCode 250.4)
Diabetic retinopathy (PheCode 250.7)
Cataplexy and narcolepsy (PheCode 347)
Atrial fibrillation and flutter (PheCode 427.2)
platelet count (maximum, inv-norm transformed)
Other anemias (PheCode 285)
Encounter for long-term (current) use of anticoagulants (PheCode 286.2)
Other and unspecified coagulation defects (PheCode 286.7)
Polycythemia, secondary (PheCode 289.8)
Cardiac dysrhythmias (PheCode 427)
Type 2 diabetes with ophthalmic manifestations (PheCode 250.23)
Atrial flutter (PheCode 427.22)
Atrial fibrillation (PheCode 427.21)
Testicular dysfunction (PheCode 257)
Testicular hypofunction (PheCode 257.1)
triglyceride (maximum, inv-norm transformed)
triglyceride (mean, inv-norm transformed)
red cell diameter width (RDW, mean, inv-norm transformed)
total cholesterol (maximum, inv-norm transformed)
systolic blood pressure (SBP, mean, inv-normal transformed)
triglyceride (minimum, inv-norm transformed)
red cell diameter width (RDW, maximum, inv-norm transformed)
systolic blood pressure (SBP, maximum, inv-normal transformed)
total cholesterol (minimum, inv-norm transformed)
Gout (PheCode 274.1)
red blood cell count (RBC, mean, inv-norm transformed)
red blood cell count (RBC, minimum, inv-norm transformed)
total cholesterol (mean, inv-norm transformed)
red blood cell count (RBC, maximum, inv-norm transformed)
red cell diameter width (RDW, minimum, inv-norm transformed)
Takes medication for gout?
Biological Sibling:  Cancer, Breast
white blood cell count (WBC, maximum, inv-norm transformed)
mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)
mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)
white blood cell count (WBC, minimum, inv-norm transformed)
Weight (mean, inv-normal transformed)
Hypertension (PheCode 401)
Weight (maximum, inv-normal transformed)
Weight (minimum, inv-normal transformed)
Essential hypertension (PheCode 401.1)
white blood cell count (WBC, mean, inv-norm transformed)
Paroxysmal tachycardia, unspecified (PheCode 427.1)
What is your weight? (pounds, inv-normal transformed)
Psychophysical visual disturbances (PheCode 368.91)
Alcoholism (PheCode 317.1)
Alcohol-related disorders (PheCode 317)
Free cholesterol levels in small HDL
Cholesteryl esters to total lipids ratio in small HDL
Cholesteryl ester levels in small HDL
Total lipid levels in lipoprotein particles
Total fatty acid levels
Total concentration of lipoprotein particles
Triglyceride levels in VLDL
Cholesterol levels in very large HDL
Cholesteryl ester levels in very large HDL
Triglyceride levels in very large VLDL
Cholesterol levels in very small VLDL
Cholesterol to total lipids ratio in very small VLDL
Triglycerides to total lipids ratio in very large VLDL
Glycine levels
Glycoprotein acetyls levels
Histidine levels
Isoleucine levels
Lactate levels
Linoleic acid levels
Phosphatidylcholine levels
Omega-3 fatty acid levels
Total cholesterol minus HDL-C levels
Triglyceride levels in small VLDL
Phospholipid levels in small VLDL
Phospholipids to total lipids ratio in small VLDL
Free cholesterol to total lipids ratio in very large HDL
Total lipid levels in very large HDL
Triglyceride levels in chylomicrons and extremely large VLDL
Acetate levels
Acetoacetate levels
Albumin levels
Acetone levels
Alanine levels
Facial morphology (segment 2)
White matter hyperintensities
Cholesterol levels in small HDL
Phospholipid levels in small HDL
Concentration of small HDL particles
Phospholipids to total lipids ratio in small HDL
Cholesterol levels in small VLDL
Triglyceride levels in small LDL
Triglycerides to total lipids ratio in small LDL
Phospholipid levels in VLDL
Total lipid levels in VLDL
Concentration of VLDL particles
Free cholesterol to total lipids ratio in very large VLDL
Total lipid levels in very large VLDL
Concentration of very large VLDL particles
Phospholipid levels in very large VLDL
Triglyceride levels in very small VLDL
Phospholipid levels in very small VLDL
Phospholipids to total lipids ratio in very small VLDL
Concentration of very small VLDL particles
Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL
Phospholipid levels in chylomicrons and extremely large VLDL
Sex hormone-binding globulin levels in premenopausal women
Sex hormone-binding globulin levels in postmenopausal women
Mean arterial pressure (BMI adjusted)
Bipolar disorder or blood urea nitrogen levels (MTAG)
Bipolar disorder or glomerular filtration rate estimated from creatine (MTAG)
Hyperthyroidism
Fibroblast growth factor 2 levels
Systolic blood pressure (BMI adjusted)
Ischemic stroke (cardioembolic)
Ulcerative colitis
Stable warfarin dose
Bipolar disorder or urate levels (MTAG)
Bipolar disorder or glomerular filtration rate estimated from cystatin (MTAG)
Plasma strontium levels
Type 2 diabetes mellitus or coronary artery disease (pleiotropy)
Plasma orotidine levels in chronic kidney disease
Urine orotidine levels in chronic kidney disease
Urine nonenedioate (C9:1-DC)* levels in chronic kidney disease
Breast cancer or ovarian cancer (pleiotropy)
Urine X-24798 levels in chronic kidney disease
Plasma X-17653 levels in chronic kidney disease
Urine X-21827 levels in chronic kidney disease
Plasma X-23680 levels in chronic kidney disease
Urine X-23680 levels in chronic kidney disease
Urine X-24330 levels in chronic kidney disease
Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease
Retinal venular width
Retinal arteriolar tortuosity
Plasma mannonate* levels in chronic kidney disease
Plasma mannose levels in chronic kidney disease
Urine pimelate (C7-DC) levels in chronic kidney disease
Sphingomyelin (d42:0) levels
Urine 4-hydroxyphenylacetoylcarnitine levels in chronic kidney disease
Plasma 2'-O-methyluridine levels in chronic kidney disease
Estimated glomerular filtration rate (creatinine)
Vaginal microbiome MetaCyc pathway (PWY-7159|chlorophyllide a biosynthesis III (aerobic, light independent))
Essential tremor
Hormone-sensitive cancer
Regional cortical thickness (parsorbitalis)
Cake icing liking
Descending thoracic aortic diameter
Crisps liking
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
Vaginal microbiome MetaCyc pathway (PWY-6507|4-deoxy-L-threo-hex-4-enopyranuronate degradation)
Vaginal microbiome relative abundance (s_Gardnerella vaginalis)
Vaginal microbiome relative abundance (p_Actinobacteriota)
Vaginal microbiome relative abundance (Lactobacillus crispatus or Lactobacillus iners or Gardnerella vaginalis) (pleiotropy)
Vaginal microbiome relative abundance (s_Lactobacillus jensenii)
Vaginal microbiome MetaCyc pathway (PWY-5507|adenosylcobalamin biosynthesis I (early cobalt insertion))
Vaginal microbiome MetaCyc pathway (PWY0-1061|superpathway of L-alanine biosynthesis)
Vaginal microbiome MetaCyc pathway (FERMENTATION-PWY|mixed acid fermentation)
Vaginal microbiome MetaCyc pathway (FUCCAT-PWY|fucose degradation)
Vaginal microbiome MetaCyc pathway (PWY-5005|biotin biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-6749|CMP-legionaminate biosynthesis I)
Vaginal microbiome relative abundance (f_Bifidobacteriaceae)
Vaginal microbiome presence (s_Lactobacillus paragasseri/gasseri)
Vaginal microbiome relative abundance (c_Actinobacteria)
Vaginal microbiome relative abundance (g_Atopobium)
Vaginal microbiome relative abundance (c_Gammaproteobacteria)
Cognitive performance (visuoconstruction) (longitudinal)
Estimated glomerular filtration rate (cystatin c)
Biological age (PhenoAge)
Low-carbohydrate diet (LCD) score
Facial wrinkles (under eye)
Vaginal microbiome MetaCyc pathway (THRESYN-PWY|superpathway of L-threonine biosynthesis)
Triacylglyceride levels
BMI at birth
Coronary artery disease
Insomnia
Non-HDL cholesterol levels
Gulonate levels in elite athletes
Campesterol levels in elite athletes
Facial morphology (segment 34)
Betonicine levels in elite athletes
Androsterone sulfate levels in elite athletes
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levels in elite athletes
Plasma ANGPTL8 levels
3,7-dimethylurate levels in elite athletes
4-allylphenol sulfate levels in elite athletes
Beta-citrylglutamate levels in elite athletes
BMI and adiposity (confirmatory factor analysis Factor 7)
Body size (confirmatory factor analysis Factor 21)
Age-related eyesight deterioration (confirmatory factor analysis Factor 27)
Inflammatory markers and poor diet (confirmatory factor analysis Factor 30)
Hypertension (confirmatory factor analysis Factor 12)
Alcohol use and misuse (confirmatory factor analysis Factor 22)
Educational attainment (confirmatory factor analysis Factor 10)
Use of dietary supplements (confirmatory factor analysis Factor 13)
Bone density (confirmatory factor analysis Factor 19)
Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)
Smoking and associated risk behaviours (confirmatory factor analysis Factor 6)
Concentration of very large HDL particles
Phospholipids in very large HDL
Total lipids in very large HDL
Phospholipids to total lipids ratio in very large HDL
Free cholesterol in very large HDL
Cholesterol esters in very large HDL
Cholesteryl esters to total lipids ratio in very large HDL
Cholesteryl esters to total lipids ratio in very small VLDL
Total lipids in very small VLDL
Free cholesterol in very small VLDL
Free cholesterol to total lipids ratio in medium VLDL
Free cholesterol in medium VLDL
Cholesteryl esters to total lipids ratio in medium VLDL
Total cholesterol to total lipids ratio in medium VLDL
Cholesterol esters in medium VLDL
Serum total triglyceride levels
Ratio of polyunsaturated fatty acids to total fatty acids
Pyruvate levels
Remnant cholesterol (non-HDL, non-LDL -cholesterol)
Serum total cholesterol levels
Omega-3 fatty acids levels
Estimated description of fatty acid chain length not actual carbon number
Esterified cholesterol levels
Docosahexaenoic acid (22:6) levels
Diacylglycerol levels
Triglycerides to total lipids ratio in very large HDL
Triglycerides in very large HDL
Total cholesterol to total lipids ratio in very large VLDL
Cholesterol esters in very large VLDL
Total cholesterol in very large VLDL
Cholesteryl esters to total lipids ratio in very large VLDL
Free cholesterol in very large VLDL
Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL
Free cholesterol levels in chylomicrons and extremely large VLDL
Cholesteryl ester levels in chylomicrons and extremely large VLDL
Triglycerides to total lipids ratio in very small VLDL
Total cholesterol levels in chylomicrons and extremely large VLDL
Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL
Triglycerides in very small VLDL
Breast cancer subtype (triple negative vs luminal A-like)
Breast cancer subtype (triple negative vs luminal B-like)
Total cholesterol in medium VLDL
Ratio of monounsaturated fatty acids to total fatty acids
Monounsaturated fatty acids (16:1, 18:1) levels
Triglycerides to total lipids ratio in medium VLDL
Polyunsaturated fatty acids
Triglycerides in medium VLDL
Phosphatidylcholine and other choline levels
Total lipids in small HDL
Triglycerides to total lipids ratio in small HDL
Phospholipids in small HDL
Triglycerides in small HDL
Free cholesterol in small HDL
Total lipids in very large VLDL
Triglycerides in very large VLDL
Phospholipids in very large VLDL
Total cholesterol to total lipids ratio in very small VLDL
Total cholesterol in very small VLDL
Phospholipids in very small VLDL
Total lipid levels in chylomicrons and extremely large VLDL
Concentration of chylomicrons and extremely large VLDL particles
Triglycerides in medium LDL
Concentration of medium VLDL particles
Phospholipids to total lipids ratio in medium VLDL
Total lipids in medium VLDL
Phospholipids in medium VLDL
Age of onset of type 1 diabetes
Total cholesterol levels in small HDL
Total cholesterol to total lipids ratio in small HDL
Saturated fatty acids
Total Cholesterol in small LDL
Free cholesterol in small LDL
Free cholesterol to total lipids ratio in small LDL
Phospholipids in small LDL
Concentration of small LDL particles
Total lipids in small LDL
Triglycerides in small LDL
Sphingomyelins levels
Total cholesterol in small VLDL
Ratio of apolipoprotein B to apolipoprotein A1 levels
Apolipoprotein A-I levels
3-Hydroxybutyrate levels
Citrate levels
Conjugated linoleic acid
Ratio of omega-6 fatty acids to total fatty acids
Omega-6 fatty acids levels
Glucose levels
Glucuronate levels in elite athletes
Pro-hydroxy-pro levels in elite athletes
Eubacterium F sp000434115 abundance in stool
Klebsiella pneumoniae abundance in stool
Klebsiella abundance in stool
Behenoyl dihydrosphingomyelin (d18:0/22:0) levels in elite athletes
Sphingomyelin (d18:1/24:1, d18:2/24:0) levels in elite athletes
Pregnanediol-3-glucuronide levels in elite athletes
Stearoyl sphingomyelin (d18:1/18:0) levels in elite athletes
Brain orotidine levels
Cerebrospinal fluid mannose levels
Ischemic stroke or factor VII levels (pleiotropy)
Fibrinogen levels or factor VII levels (pleiotropy)
Choline phosphate levels in elite athletes
Coronary artery disease or factor VII levels (pleiotropy)
UBA6398 abundance in stool
Palmitoyl-arachidonoyl-glycerol (16:0/20:4) [1] levels in elite athletes
Fibrinogen levels or factor VII levels or factor XI levels or tissue plasminogen activator levels (pleiotropy)
Venous thromboembolism or factor VII levels (pleiotropy)
Cholesterol to total lipids ratio in small HDL
Total lipid levels in small HDL
Concentration of medium HDL particles
Free cholesterol to total lipids ratio in small VLDL
Total lipid levels in small VLDL
Concentration of small VLDL particles
Average diameter for VLDL particles
Free cholesterol levels in very large VLDL
Total esterified cholesterol levels
Total free cholesterol levels
Alcohol consumption x playing computer games interaction
Triglyceride levels in small HDL
Ratio of triglycerides to phosphoglycerides
Total concentration of branched-chain amino acids (leucine + isoleucine + valine)
Ratio of saturated fatty acids to total fatty acids
Sphingomyelin levels
Apolipoprotein B levels x vegetarianism interaction
Gestational diabetes
Testosterone levels in postmenopausal women
Cognitive domain scores for language
Annual frequency of asthma exacerbations in non-smokers
Omega-6 fatty acid levels
Ratio of omega-6 fatty acids to omega-3 fatty acids
Cholesterol to total lipids ratio in small VLDL
Cholesteryl esters to total lipids ratio in small VLDL
Cholesteryl ester levels in small VLDL
Free cholesterol levels in very large HDL
Cholesteryl ester levels in very small VLDL
Docosahexaenoic acid levels
Glutamine levels
Phosphoglycerides levels
Ratio of polyunsaturated fatty acids to monounsaturated fatty acids
Free cholesterol levels in small VLDL
Phospholipid levels in very large HDL
Free cholesterol to total lipids ratio in very small VLDL
Total lipid levels in very small VLDL
Estimated glomerular filtration rate (adjusted for BMI) x vegetarianism interaction
Cholesterol levels in small LDL
Cholesteryl esters to total lipids ratio in small LDL
Cholesteryl ester levels in small LDL
Total phospholipid levels in lipoprotein particles
Degree of unsaturation
Free cholesterol levels in small LDL
Triglycerides to total lipids ratio in small VLDL
Saturated fatty acid levels
Triglyceride levels in very large HDL
Cholesterol levels in medium HDL
Leucine levels
Polyunsaturated fatty acid levels
Phenylalanine levels
Tanner 3 to Tanner 4 pubertal stage transition (joint longitudinal BMI and survival model)
Total phosphoglycerides levels
Estimated degree of unsaturation
Valine levels
Total cholines levels
Total fatty acids
acne vulgaris
Triglycerides in small VLDL
Total cholesterol to total lipids ratio in small VLDL
Cholesterol esters in small VLDL
Free cholesterol in small VLDL
Nonalcoholic fatty liver disease (imputed)
Total lipids in small VLDL
Phospholipids in small VLDL
Total cholesterol levels in VLDL
Mean diameter of VLDL particles
Total cholesterol levels in very large HDL
Total cholesterol to total lipids ratio in very large HDL
Total protein levels
Basal ganglia structure
Alkaline phosphatase levels
Serum chloride levels
Total cholesterol levels in LDL
Triglyceride levels in LDL
Mean diameter of LDL particles
Total cholesterol to total lipids ratio in large HDL
Total cholesterol in large HDL
Ratio of 18:2 linoleic acid to total fatty acids
Cholesterol esters in large HDL
Cholesteryl esters to total lipids ratio in large HDL
Total lipids in large HDL
Free cholesterol to total lipids ratio in large HDL
Free cholesterol in large HDL
Phospholipids in large HDL
Phospholipids to total lipids ratio in large HDL
Triglycerides to total lipids ratio in large HDL
Phospholipids in large LDL
Concentration of large LDL particles
Total lipids in large LDL
Total cholesterol levels in medium HDL
Total cholesterol to total lipids ratio in medium HDL
Triglycerides to total lipids ratio in large VLDL
Cholesterol esters in medium HDL
Cholesteryl esters to total lipids ratio in medium HDL
Triglycerides in large VLDL
Total Cholesterol in IDL
Concentration of IDL particles
Total lipids in IDL
Triglycerides to total lipids ratio in IDL
Linoleic acid (18:2) levels
Triglycerides in IDL
Free cholesterol to total lipids ratio in large LDL
Cholesterol esters in large LDL
Triglycerides to total lipids ratio in large LDL
Total Cholesterol in large VLDL
Total cholesterol to total lipids ratio in large VLDL
Triglycerides in large LDL
Free cholesterol in large VLDL
Free cholesterol to total lipids ratio in large VLDL
Total lipids in large VLDL
Cholesteryl esters to total lipids ratio in large VLDL
Concentration of large VLDL particles
Cholesterol esters in large VLDL
Phospholipids in large VLDL
Total cholesterol in HDL3
Total cholesterol in HDL2
Triglyceride levels in HDL
Mean diameter of HDL particles
Total cholesterol levels in HDL
Phospholipids to total lipids ratio in IDL
Free cholesterol levels
Glycerol levels
Glycoprotein acetylation
Total cholesterol to total lipids ratio in IDL
Free cholesterol to total lipids ratio in IDL
Concentration of large HDL particles
Free cholesterol in medium HDL
Free cholesterol to total lipids ratio in medium HDL
Total lipids in medium HDL
Triglycerides in medium HDL
Phospholipids in medium HDL
Triglycerides to total lipids ratio in medium HDL
Vitamin D insufficiency
Glycogen phosphorylase, liver form levels (PYGL.11441.11.3)
Phosphoglucomutase-1 levels (PGM1.9173.21.3)
Fatty acid-binding protein, liver levels (FABP1.11516.7.3)
Cholesterol levels in large VLDL
Cholesterol levels in IDL
Average diameter for HDL particles
Cholesterol to total lipids ratio in IDL
Cholesteryl ester levels in IDL
Cholesteryl esters to total lipids ratio in IDL
Free cholesterol levels in IDL
Total lipid levels in IDL
Phospholipid levels in IDL
Triglyceride levels in IDL
Cholesterol levels in large HDL
Cholesteryl ester levels in large HDL
Cholesterol to total lipids ratio in large HDL
Free cholesterol levels in large HDL
Total lipid levels in large HDL
Phospholipid levels in large HDL
Triglyceride levels in large HDL
Cholesterol levels in large LDL
Cholesteryl ester levels in large LDL
Cholesterol to total lipids ratio in large LDL
Cholesteryl esters to total lipids ratio in large LDL
Free cholesterol levels in large LDL
Phospholipids to total lipids ratio in large LDL
Phospholipid levels in large LDL
Total lipid levels in large LDL
Triglyceride levels in large LDL
Cholesterol to total lipids ratio in large VLDL
Cholesteryl ester levels in large VLDL
Prostate-specific antigen levels
Malignant neoplasm of female breast (PheCode 174.11)
Breast cancer [female] (PheCode 174.1)
Sodium (mean, inv-norm transformed)
heart rate (HR, minimum, inv-normal transformed)
Retinal thickness (pixel 66_60)
Retinal thickness (pixel 113_16)
Overweight, obesity and other hyperalimentation (PheCode 278)
Retinal thickness (functional principal component 4)
Retinal nerve fibre layer (RNFL) thickness
Disorders of lipid metabolism (PheCode 272)
Gouty arthropathy (PheCode 274.11)
Gestational diabetes mellitus
Insulin-resistant gestational diabetes mellitus
Hyperlipidemia (PheCode 272.1)
Morbid obesity (PheCode 278.11)
Obesity (PheCode 278.1)
Body mass index (BMI, minimum, inv-normal transformed)
Blood urea nitrogen (BUN, mean, inv-norm transformed)
Takes medication for high cholesterol?
Blood urea nitrogen (BUN, maximum, inv-norm transformed)
Calcium (maximum, inv-norm transformed)
Blood urea nitrogen (BUN, minimum, inv-norm transformed)
High blood pressure / hypertension
Calcium (mean, inv-norm transformed)
High cholesterol
Tyrosine levels
Gout and other crystal arthrop (PheCode 274)
diastolic blood pressure (DBP, maximum, inv-normal transformed)
Body fat distribution (arm fat ratio)
Body fat distribution (leg fat ratio)
Takes medication for Diabetes/sugar?
Body fat distribution (trunk fat ratio)
diastolic blood pressure (DBP, mean, inv-normal transformed)
Takes medication for high blood pressure?
Biological Father: High cholesterol
creatinine (minimum, inv-norm transformed)
creatinine (mean, inv-norm transformed)
Diabetes / "Sugar"
Night sleep phenotypes
hematocrit (mean, inv-norm transformed)
hematocrit (minimum, inv-norm transformed)
high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)
Glucose (fasting status unknown, maximum, inv-norm transformed)
Glucose (fasting status unknown, minimum, inv-norm transformed)
hematocrit (maximum, inv-norm transformed)
Glucose (fasting status unknown, mean, inv-norm transformed)
Body mass index (BMI, maximum, inv-normal transformed)
high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)
high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)
Height (maximum, inv-normal transformed)
Left ventricular mass indexed by body surface area
Right ventricular stroke volume
Right ventricular end diastolic volume
Descending aorta diameter
FVC
C-reactive protein levels (MTAG)
High-density lipoprotein levels (MTAG)
Low-density lipoprotein levels (MTAG)
Triglyceride levels (MTAG)
Body mass index (MTAG)
Apolipoprotein E levels
Glycogen phosphorylase, liver form levels
Ganglioside GM2 activator levels
GDNF family receptor alpha-like levels
Retinoic acid receptor responder protein 3 levels
Lysosomal alpha-glucosidase levels
EGF-containing fibulin-like extracellular matrix protein 1 levels
Melanoma-associated antigen 10 levels
RBC levels of Pyridoxamine
Metachronous colorectal adenoma
Glucokinase regulatory protein levels
Phosphoglucomutase-1 levels
PIK3CA/PIK3R1 levels
Beta-defensin 1 levels
Inhibin beta A chain levels
Beta-enolase levels
Beta-klotho levels
DCN1-like protein 5 levels
Peak expiratory flow
Mannose levels
Beta-hydroxyisovalerate levels
Serine levels
Orbital telorism
Very low density lipoprotein cholesterol levels
Adipoylcarnitine (C6-DC) levels
Monounsaturated fatty acid levels
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels
AFP levels
X-23680 levels
X-24295 levels
X-17654 levels
X-18921 levels
X-19438 levels
1-myristoyl-2-docosahexaenoyl-GPC (14:0/22:6) levels
2'-o-methylcytidine levels
2'-o-methyluridine levels
X-11378 levels
Circulating docosahexaenoic acid levels
Total omega-3 fatty acid levels
Total omega-6 fatty acid levels
Cardioembolic stroke (MTAG)
Factor VII levels
Smoking initiation
Fibroblast growth factor 21 levels
Interleukin-12 subunit beta levels
Fms-related tyrosine kinase 3 ligand levels
Drinks per week
3-methoxytyrosine levels
3-(4-hydroxyphenyl) lactate levels
3-hydroxydecanoate levels
3-hydroxyoctanoate levels
Tetradecadienoate (14:2) (X-12442) levels
Cigarettes smoked per day
Dodecadienoate (12:2) (X-21343) levels
Gamma-glutamylthreonine levels
Cis-4-decenoate (10:1n6) (X-23293) levels
Imidazole lactate levels
Malate levels
N-acetylhistidine levels
Triglyceride levels in non-type 2 diabetes
Body surface area
Hypertension complicating pregnancy
Back pain
X-24309 levels
Glycerophosphorylcholine (GPC) levels
N-acetylserine levels
N-acetylthreonine levels
X-23293 levels
X-23297 levels
X-23639 levels
Xanthine levels
1-linolenoyl-GPC (18:3) levels
1-arachidonoyl-gpc (20:4n6) levels
1-docosahexaenoyl-GPE (22:6) levels
Vanillylmandelate (VMA) levels
X-11308 levels
X-16935 levels
X-13529 levels
X-12442 levels
lysoPhosphatidylcholine acyl C16:0 levels
lysoPhosphatidylcholine acyl C16:1 levels
lysoPhosphatidylcholine acyl C20:3 levels
Phosphatidylcholine diacyl C34:4 levels
Triacylglycerol (54:4) levels
Triacylglycerol (54:5) levels
Triacylglycerol (54:6) levels
Triacylglycerol (54:7) levels
Triacylglycerol (56:6) levels
Triacylglycerol (56:7) levels
Sphingomyelin (d32:1) levels
Triacylglycerol (46:2) levels
Triacylglycerol (48:1) levels
Triacylglycerol (48:2) levels
Triacylglycerol (48:3) levels
Triacylglycerol (49:2) levels
Triacylglycerol (50:1) levels
Triacylglycerol (50:2) levels
Triacylglycerol (50:3) levels
Triacylglycerol (50:4) levels
Triacylglycerol (50:5) levels
Triacylglycerol (51:2) levels
Triacylglycerol (51:3) levels
Triacylglycerol (51:4) levels
Triacylglycerol (52:2) levels
Triacylglycerol (52:3) levels
Triacylglycerol (52:4) levels
Triacylglycerol (52:5) levels
Triacylglycerol (52:6) levels
Triacylglycerol (53:2) levels
Triacylglycerol (53:3) levels
Triacylglycerol (53:4) levels
Sphingomyelin (d40:2) levels
Triacylglycerol (58:7) levels
Hepatocyte growth factor-like protein levels
Change in intelligence quotient in pediatric CNS tumors treated with craniospinal irradiation
Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)
Adipoylcarnitine levels
1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels
1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) levels
1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6) levels
1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels
2-hydroxybutyrate/2-hydroxyisobutyrate levels
Indoleacetylglutamine levels
1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPE (p-16:0/22:6) levels
3-(4-hydroxyphenyl)lactate levels
3-hydroxylaurate levels
3-methyl-2-oxovalerate levels
Succinate levels
Taurocholenate sulfate levels
Threonine levels
Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)
5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels
4-methyl-2-oxopentanoate levels
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) levels
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6) levels
1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2) levels
1-palmitoyl-GPC (16:0) levels
1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) levels
Kynurenate levels
Kynurenine levels
1-myristoyl-2-linoleoyl-GPC (14:0/18:2) levels
1-myristoyl-GPC (14:0) levels
Quinolinate levels
Retinol (Vitamin A) levels
1-oleoyl-2-linoleoyl-glycerol (18:1/18:2) levels
1-oleoyl-3-linoleoyl-glycerol (18:1/18:2) levels
X-17653 levels
X-21736 levels
X-22145 levels
X-21343 levels
X-21353 levels
X-21607 levels
X-19141 levels
3-ketoacyl-CoA thiolase, peroxisomal levels
Glycerol-3-phosphate phosphatase levels
3-hydroxybutyrate dehydrogenase type 2 levels
Neutrophil cytosol factor 1 levels
Fatty acid-binding protein, liver levels
Alpha-L-fucoside fucohydrolase levels
Fms-related tyrosine kinase 3 ligand (analyte X14093.10) levels
Klotho levels
Lactotransferrin (analyte X2780.35) levels
Fructose-1,6-bisphosphatase isozyme 2 levels
Insulin receptor levels
Cancer (standard GWA)
Height (standard GWA)
Pulmonary embolism
LDL (standard GWA)
BMI (standard GWA)
Systolic blood pressure (standard GWA)
Dupuytren's disease
Eye color
Bicarbonate (mean, inv-norm transformed)
Bicarbonate (minimum, inv-norm transformed)
Bicarbonate (maximum, inv-norm transformed)
Cirrhosis
End-diastolic bi-ventricular shape (principal component 2)
Mixed hyperlipidemia (PheCode 272.13)
Body mass index (BMI, mean, inv-normal transformed)
Simple and unspecified goiter (PheCode 240)
Nontoxic uninodular goiter (PheCode 241.1)
Nontoxic multinodular goiter (PheCode 241.2)
Nontoxic nodular goiter (PheCode 241)
Youth-onset type 2 diabetes
monocyte (fraction, mean, inv-norm transformed)
Stem Cell Growth Factor-beta levels
Early onset colorectal cancer
monocyte (absolute count, maximum, inv-norm transformed)
Hereditary and idiopathic peripheral neuropathy (PheCode 356)
monocyte (absolute count, mean, inv-norm transformed)
monocyte (absolute count, minimum, inv-norm transformed)
Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)
Type 1 diabetes with neurological manifestations (PheCode 250.14)
Type 1 diabetes with ketoacidosis (PheCode 250.11)
Hypothyroidism NOS (PheCode 244.4)
Hypothyroidism (PheCode 244)
Biological Mother:  Cancer, Breast
neutrophil (absolute count, mean, inv-norm transformed)
Viral Enteritis (PheCode 8.6)
lymphocyte (fraction, maximum, inv-norm transformed)
monocyte (fraction, maximum, inv-norm transformed)
low density lipoprotein cholesterol (LDLC, minimum, inv-norm transformed)
lymphocyte (absolute count, minimum, inv-norm transformed)
monocyte (fraction, minimum, inv-norm transformed)
Dyslexia
Circulating fibroblast growth factor 21 levels
Gluteofemoral adipose tissue volumes (adjusted for BMI and height)
R-6-hydroxywarfarin to R-warfarin ratio
Colorectal cancer x estrogen-progesterone hormone therapy interaction
Colorectal cancer x menopausal hormone therapy interaction (3df test)
R-6-hydroxywarfarin levels
RS-10-hydroxywarfarin levels
Maximum habitual alcohol consumption (MTAG)
Maximum habitual alcohol consumption
Chronic elevation of alanine aminotransferase (cALT) levels
Free cholesterol levels in HDL
Total lipid levels in HDL
Cholesteryl ester levels in HDL
Phospholipid levels in HDL
Concentration of HDL particles
Descending aorta maximum area
Carnitine C9 levels
Metabolite peak levels (QI648)
Metabolite peak levels (QI6204)
Metabolite peak levels (QI6252)
N6-methyllysine levels
Metabolite peak levels (QI618)
Metabolite peak levels (QI619)
Metabolite peak levels (QI15802)
Metabolite peak levels (QI15804)
Metabolite peak levels (QI15587)
Metabolite peak levels (QI15625)
Metabolite peak levels (QI15628)
Metabolite peak levels (QI15633)
Metabolite peak levels (QI15785)
Metabolite peak levels (QI9845)
Metabolite peak levels (QI409)
Metabolite peak levels (QI510)
Metabolite peak levels (QI565)
Metabolite peak levels (QI588)
Descending aorta maximum area (MTAG)
Metabolite peak levels (QI15545)
Metabolite peak levels (QI9680)
Free cholesterol levels in large VLDL
Total lipid levels in large VLDL
Triglyceride levels in large VLDL
Phospholipid levels in large VLDL
Phospholipids to total lipids ratio in large VLDL
Cholesteryl ester levels in LDL
Ratio of linoleic acid to total fatty acids
Free cholesterol levels in LDL
Phospholipid levels in LDL
Total lipid levels in LDL
Average diameter for LDL particles
Cholesterol to total lipids ratio in medium HDL
Cholesteryl ester levels in medium HDL
Free cholesterol levels in medium HDL
Total lipid levels in medium HDL
Phospholipids to total lipids ratio in medium HDL
Phospholipid levels in medium HDL
Cholesterol to total lipids ratio in medium LDL
Triglyceride levels in medium HDL
Cholesterol levels in medium LDL
Cholesteryl esters to total lipids ratio in medium LDL
Cholesteryl ester levels in medium LDL
Free cholesterol to total lipids ratio in medium LDL
Free cholesterol levels in medium LDL
Total lipid levels in medium LDL
Phospholipid levels in medium LDL
Concentration of medium LDL particles
Phospholipids to total lipids ratio in medium LDL
Triglyceride levels in medium LDL
Triglycerides to total lipids ratio in medium LDL
Cholesterol to total lipids ratio in medium VLDL
Free cholesterol levels in medium VLDL
Alzheimer's disease or educational attainment (pleiotropy)
Total lipid levels in medium VLDL
Phospholipid levels in medium VLDL
Triglyceride levels in medium VLDL
Ratio of omega-3 fatty acids to total fatty acids
Phospholipid levels in small LDL
Phospholipids to total lipids ratio in small LDL
Total lipid levels in small LDL
Free cholesterol levels in VLDL
Cholesteryl ester levels in VLDL
VLDL cholesterol levels
Cholesterol levels in very large VLDL
Cholesterol to total lipids ratio in very large VLDL
Cholesteryl ester levels in very large VLDL
Cholesterol levels in chylomicrons and extremely large VLDL
Clinical LDL cholesterol levels
Free cholesterol in medium LDL
Phospholipids in medium LDL
Total cholesterol in medium LDL
Dry eye disease
Gamma-enolase levels
BMI-adjusted waist-hip ratio
Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)
Pulse pressure x low social support interaction (2df test)
Pulse pressure x low social support interaction (1df test)
Diastolic blood pressure x depressive symptoms interaction (2df test)
Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy)
Dietary macronutrient intake (multi-trait analysis)
Intrahepatic cholestasis of pregnancy
Insomnia in migraine with aura
Non-small cell lung cancer x BMI trajectory interaction
Alcohol consumption (drinks per month) (UKB data field 1578, 4424)
Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)
Cereal consumption (bowls per week) (UKB data field 1458)
Hearing loss
Uterine leiomyomata
Cataract
Principal component-derived dietary pattern 8
Right ventricular stroke volume (MTAG)
Right ventricular end systolic volume
Predicted heart recovery rate
Uterine leiomyoma or breast cancer (pleiotropy)
X-12442--5,8-tetradecadienoate levels
X-13435 levels
Glucose-to-mannose ratio
Heart failure
1-palmitoleoylglycerol (16:1) levels
Palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] levels
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] levels
1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) levels
Early-onset ischemic stroke
Serum glutamic-oxaloacetic transaminase levels
Sleep health score
Myristoyl-linoleoyl-glycerol (14:0/18:2) [1] levels
1-carboxyethylphenylalanine levels
1-carboxyethylvaline levels
1-carboxyethylleucine levels
1-carboxyethylisoleucine levels
Mannonate levels
1-myristoylglycerol (14:0) levels
2-myristoyl-GPC (14:0) levels
1-palmitoyl-GPE (16:0) levels
1-stearoyl-2-oleoyl-GPE (18:0/18:1) levels
1-stearoyl-GPE (18:0) levels
Acylcarnitine (13:0) levels
Phosphatidylcholine diacyl C40:5 levels
Phosphatidylcholine diacyl C40:6 levels
Phosphatidylcholine diacyl C32:1 levels
Phosphatidylcholine diacyl C32:2 levels
Phosphatidylcholine diacyl C34:1 levels
Phosphatidylcholine diacyl C34:3 levels
Phosphatidylcholine diacyl C36:5 levels
Phosphatidylcholine diacyl C36:6 levels
Phosphatidylcholine diacyl C38:5 levels
Vertex-wise sulcal depth
Vertex-wise cortical thickness
Systolic blood pressure (BMI unadjusted)
cGMP-specific 3',5'-cyclic phosphodiesterase levels
High-sensitivity cardiac troponin I concentration
Triacylglycerol (52:3) [NL-16:1] levels
Asthma-COPD overlap syndrome
Vertex-wise cortical surface area
Total Phosphatidylglycerol levels
Total Trihexosylcermide levels
Bone mineral density (spine)
Trihexosylcermide (d18:1/16:0) levels
Trihexosylcermide (d18:1/18:0) levels
Trihexosylcermide (d18:1/22:0) levels
Asparagine levels
Triacylglycerol (48:2) [NL-16:0] levels
lysoPhosphatidylcholine acyl C14:0 levels
lysoPhosphatidylcholine acyl C18:0 levels
Fasting glucose adjusted for BMI
Glycated haemoglobin HbA1c levels adjusted for BMI
Fasting insulin adjusted for BMI
EMILIN-3 level in Chronic kidney disease with hypertension and no diabetes (8773_172)
Phosphatidylinositol (16:0_20:4) levels
Phosphatidylinositol (18:0_20:4) levels
Phosphatidylcholine (14:0_18:1) levels
Phosphatidylcholine (18:0_22:5) levels
Phosphatidylethanolamine (16:0_18:2) levels
Phosphatidylethanolamine (18:0_18:2) levels
Phosphatidylethanolamine (18:2_0:0) levels
Coagulation factor IX levels
Coagulation factor IXab levels
Ceramide (d40:1) levels
Sterol ester (27:1/18:3) levels
Diacylglycerol (18:1_18:2) levels
Phosphatidylcholine (16:0_0:0) levels
Diacylglycerol (16:1_18:1) levels
Diacylglycerol (18:1_18:1) levels
Phosphatidylcholine (16:1_18:0) levels
Phosphatidylcholine (16:1_18:2) levels
Phosphatidylcholine (16:0_16:1) levels
Phosphatidylcholine (16:0_18:1) levels
Phosphatidylcholine (16:0_18:3) levels
Phosphatidylcholine (16:1_18:1) levels
Phosphatidylcholine (16:0_20:2) levels
Inorganic pyrophosphatase 2, mitochondrial levels
Keratin, type I cytoskeletal 19 levels
Chondrocalcin levels
Sleep apnea (MTAG)
Prostaglandin reductase 2 levels
Quinone oxidoreductase-like protein 1 levels
Cytokine SCM-1 beta levels
Signal peptide, CUB and EGF-like domain-containing protein 1 levels
ADP-ribosylation factor GTPase-activating protein 1 levels
Insulin-like growth factor-binding protein 1 levels
Inactive gamma-glutamyltranspeptidase 2 levels
Interleukin-22 receptor subunit alpha-2 levels
Enoyl-CoA delta isomerase 2, mitochondrial levels
Eukaryotic elongation factor 2 kinase levels
Complement component C1q receptor levels
Group XIIB secretory phospholipase A2-like protein levels
Sialic acid-binding Ig-like lectin 12 levels
SLIT and NTRK-like protein 6 levels
Somatoliberin levels
Cathepsin F levels
Palmitoleoyl-protein carboxylesterase NOTUM levels
RGM domain family member B levels
Liver carboxylesterase 1 levels
Leptin receptor levels
Liver-expressed antimicrobial peptide 2 levels
Leukocyte immunoglobulin-like receptor subfamily A member 5 levels
Mitogen-activated protein kinase 3 levels
MANSC domain-containing protein 1 levels
Resistance to COVID-19 infection (Exposed negative vs positive)
Chronic obstructive pulmonary disease liability (machine learning-based score)
Severe COVID-19 infection
Cigarettes smoked per day (MTAG)
Photoreceptor cell layer thickness phenotypes (MTAG)
Liver proton density fat fraction
Body composition (MOSTest)
Medication use for T2D (number of purchases)
Idiopathic knee osteoarthritis
Physical activity
Alcohol frequency weekly (standard GWA)
Height (weighted GWA)
Primary focal segmental glomerulosclerosis in chronic kidney disease
tRNA (guanine-N(7)-)-methyltransferase levels
Tumor protein p53-inducible protein 11 levels
Tumor necrosis factor receptor superfamily member 1B levels
Tubulointerstitial nephritis antigen-like levels
Acetyl-CoA acetyltransferase, mitochondrial levels
Transmembrane and coiled-coil domains protein 3 levels
Neurotrimin levels
Opioid-binding protein/cell adhesion molecule levels
Neuropilin-1 levels
Fructose-1,6-bisphosphatase 1 levels
Endosialin levels
Very long-chain acyl-CoA synthetase levels
Alpha-1B-glycoprotein levels
ATP-dependent 6-phosphofructokinase, muscle type levels
Acyl-coenzyme A thioesterase 8 levels
Fructose-bisphosphate aldolase B levels
Vasorin levels
Alpha- and gamma-adaptin-binding protein p34 levels
Malonyl-CoA decarboxylase, mitochondrial levels
Neural cell adhesion molecule 1, 120 kDa isoform levels
Fibroblast growth factor 19 levels
Fibroblast growth factor receptor 1 levels
Follistatin-related protein 3 levels
Apolipoprotein A1 levels (UKB data field 23440)
Omega-3 fatty acids levels (UKB data field 23444)
Degree of unsaturation (UKB data field 23443)
Total fatty acids levels (UKB data field 23442)
3-hydroxybutyrate levels (UKB data field 23474)
Acetate levels (UKB data field 23475)
Acetoacetate levels (UKB data field 23476)
Acetone levels (UKB data field 23477)
Alanine levels (UKB data field 23460)
Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464)
Glucose levels (UKB data field 23470)
Lactate levels (UKB data field 23471)
Pyruvate levels (UKB data field 23472)
Isoleucine levels (UKB data field 23465)
Leucine levels (UKB data field 23466)
Valine levels (UKB data field 23467)
Citrate levels (UKB data field 23473)
Glutamine levels (UKB data field 23461)
Concentration of large VLDL particles (UKB data field 23495)
Total lipids in large VLDL (UKB data field 23496)
Phospholipids in large VLDL (UKB data field 23497)
Cholesterol in large VLDL (UKB data field 23498)
Total lipids in IDL (UKB data field 23524)
Triglycerides in very small VLDL (UKB data field 23522)
Concentration of large HDL particles (UKB data field 23558)
Cholesterol in large HDL (UKB data field 23561)
Phospholipids in large HDL (UKB data field 23560)
Total lipids in large HDL (UKB data field 23559)
Free cholesterol to total lipids in medium VLDL percentage (UKB data field 23597)
Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)
Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598)
Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)
Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)
Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)
Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)
Cholesterol to total lipids in large HDL percentage (UKB data field 23635)
Phospholipids to total lipids in very large HDL percentage (UKB data field 23629)
Phospholipids to total lipids in large HDL percentage (UKB data field 23634)
Total esterified cholesterol levels (UKB data field 23415)
Phospholipids in LDL (UKB data field 23413)
Cholesteryl esters in LDL (UKB data field 23417)
Phospholipids in HDL (UKB data field 23414)
Saturated fatty acids levels (UKB data field 23448)
Omega-6 fatty acids levels (UKB data field 23445)
Polyunsaturated fatty acids levels (UKB data field 23446)
Monounsaturated fatty acids levels (UKB data field 23447)
Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)
Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)
Total lipids in very large VLDL (UKB data field 23489)
Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)
Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)
Concentration of very large VLDL particles (UKB data field 23488)
Total lipids in small VLDL (UKB data field 23510)
Phospholipids in small LDL (UKB data field 23546)
Free cholesterol in medium HDL (UKB data field 23570)
Concentration of small HDL particles (UKB data field 23572)
Free cholesterol in small HDL (UKB data field 23577)
Cholesteryl esters in small HDL (UKB data field 23576)
Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579)
Cholesterol in small HDL (UKB data field 23575)
Phospholipids in small HDL (UKB data field 23574)
Triglycerides in small HDL (UKB data field 23578)
Triglycerides in medium HDL (UKB data field 23571)
Total lipids in small HDL (UKB data field 23573)
Triglycerides to total lipids in medium LDL percentage (UKB data field 23623)
Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)
Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)
Phospholipids to total lipids in small LDL percentage (UKB data field 23624)
Triglycerides to total lipids in small LDL percentage (UKB data field 23628)
Total cholesterol levels (MTAG)
Color vision defects (Tritan)
Antipsychotic-induced triglycerides change in schizophrenia (4-week)
Male puberty timing (late vs. average onset facial hair)
Male puberty timing (age at voice breaking MTAG)
ICD10 I63: Cerebral infarction
Hyperplasia of prostate (Union N40)
Headache or fasting insulin levels
Headache or HbA1c levels
Breast dense area
Neutrophil perturbation response (neutrophil 2/neutrophil 4 ratio in response to KCl perturbation measured by WDF dye)
Neutrophil perturbation response (side fluorescence standard deviation of neutrophil 4 in response to alhydrogel perturbation measured by WDF dye)
Lung function (forced vital capacity)
Cholesteryl esters in HDL (UKB data field 23418)
Total free cholesterol levels (UKB data field 23419)
Free cholesterol in VLDL (UKB data field 23420)
Triglycerides in medium LDL (UKB data field 23543)
Phospholipids in medium LDL (UKB data field 23539)
Phospholipids in medium HDL (UKB data field 23567)
Cholesterol in medium HDL (UKB data field 23568)
Cholesteryl esters in medium HDL (UKB data field 23569)
Free cholesterol to total lipids in very small VLDL percentage (UKB data field 23607)
Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)
Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)
Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)
Phospholipids to total lipids in IDL percentage (UKB data field 23609)
Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642)
Triglycerides to total lipids in medium HDL percentage (UKB data field 23643)
Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)
Cholesterol to total lipids in small HDL percentage (UKB data field 23645)
Insulin resistance
Total cholesterol levels (UKB data field 23400)
Total cholesterol minus HDL-C levels (UKB data field 23401)
Total concentration of lipoprotein particles (UKB data field 23427)
Total lipids in lipoprotein particles (UKB data field 23423)
Free cholesterol in HDL (UKB data field 23422)
Total lipids in LDL (UKB data field 23425)
Total lipids in HDL (UKB data field 23426)
Total lipids in VLDL (UKB data field 23424)
Average diameter for LDL particles (UKB data field 23432)
Average diameter for VLDL particles (UKB data field 23431)
Concentration of VLDL particles (UKB data field 23428)
Concentration of HDL particles (UKB data field 23430)
Triglycerides in very large VLDL (UKB data field 23494)
Cholesterol in very large VLDL (UKB data field 23491)
Phospholipids in very large VLDL (UKB data field 23490)
Cholesteryl esters in very large VLDL (UKB data field 23492)
Free cholesterol in very large VLDL (UKB data field 23493)
Triglycerides in small VLDL (UKB data field 23515)
Concentration of very large HDL particles (UKB data field 23551)
Total lipids in very large HDL (UKB data field 23552)
Triglycerides in small LDL (UKB data field 23550)
Phospholipids in very large HDL (UKB data field 23553)
Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582)
Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)
Triglycerides to total lipids in very large VLDL percentage (UKB data field 23588)
Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586)
Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)
Triglycerides to total lipids in IDL percentage (UKB data field 23613)
Free cholesterol to total lipids in IDL percentage (UKB data field 23612)
Cholesterol to total lipids in IDL percentage (UKB data field 23610)
Phospholipids to total lipids in large LDL percentage (UKB data field 23614)
Cholesterol to total lipids in large LDL percentage (UKB data field 23615)
Cholesteryl esters to total lipids in IDL percentage (UKB data field 23611)
Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646)
Triglycerides to total lipids in small HDL percentage (UKB data field 23648)
Free cholesterol to total lipids in small HDL percentage (UKB data field 23647)
Total phospholipids in lipoprotein particles (UKB data field 23411)
Triglycerides in VLDL (UKB data field 23408)
Phospholipids in VLDL (UKB data field 23412)
Triglycerides in LDL (UKB data field 23409)
Triglycerides in HDL (UKB data field 23410)
Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)
Omega-3 fatty acids to total fatty acids percentage (UKB data field 23451)
Docosahexaenoic acid levels (UKB data field 23450)
Omega-6 fatty acids to omega-3 fatty acids ratio (UKB data field 23459)
Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)
Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)
Saturated fatty acids to total fatty acids percentage (UKB data field 23455)
Linoleic acid to total fatty acids percentage (UKB data field 23456)
Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)
Concentration of small VLDL particles (UKB data field 23509)
Triglycerides in medium VLDL (UKB data field 23508)
Triglycerides in large LDL (UKB data field 23536)
Cholesterol in large LDL (UKB data field 23533)
Total lipids in large LDL (UKB data field 23531)
Phospholipids in large LDL (UKB data field 23532)
Cholesteryl esters in large LDL (UKB data field 23534)
Free cholesterol in large HDL (UKB data field 23563)
Concentration of medium HDL particles (UKB data field 23565)
Cholesteryl esters in large HDL (UKB data field 23562)
Total lipids in medium HDL (UKB data field 23566)
Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)
Cholesterol to total lipids in small VLDL percentage (UKB data field 23600)
Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601)
Triglycerides to total lipids in small VLDL percentage (UKB data field 23603)
Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604)
Free cholesterol to total lipids in large HDL percentage (UKB data field 23637)
Triglycerides to total lipids in large HDL percentage (UKB data field 23638)
Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636)
Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)
Phospholipids to total lipids in medium HDL percentage (UKB data field 23639)
HDL cholesterol levels (UKB data field 23406)
LDL cholesterol levels (UKB data field 23405)
Total triglycerides levels (UKB data field 23407)
Mitochondrial DNA heteroplasmy (chrM:955:A:AC case-only heteroplasmy)
4-hydroxyphenylacetoylcarnitine levels
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels
Neurocognitive measure (immediate recall) in obsessive-compulsive disorder
Systemic lupus erythematosus (MTAG)
Sphingomyelin (d40:1) levels
X-18888 levels
Dodecadienoate (12:2) levels
Vitamin D levels or COVID-19 (MTAG)
Phosphatidylcholine (17:0_18:1) levels
(2 or 3)-decenoate (10:1n7 or n8) levels
Indoleacetoylcarnitine levels
Free androgen index
3-hydroxysebacate levels
Cis-4-decenoate (10:1n6) levels
Phosphatidylcholine (16:0_17:1) levels
Sterol ester (27:1/16:1) levels
Diacylglycerol (18:1_18:3) levels
Phosphatidylethanolamine (18:0_0:0) levels
Phosphatidylcholine (14:0_18:2) levels
Phosphatidylcholine (15:0_18:1) levels
Total cholines levels (UKB data field 23436)
Phosphatidylcholines levels (UKB data field 23437)
Average diameter for HDL particles (UKB data field 23433)
Phosphoglycerides levels (UKB data field 23434)
Triglycerides to phosphoglycerides ratio (UKB data field 23435)
Sphingomyelins levels (UKB data field 23438)
Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)
Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)
Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)
Albumin levels (UKB data field 23479)
Glycoprotein acetyls levels (UKB data field 23480)
Total lipids in medium VLDL (UKB data field 23503)
Cholesteryl esters in large VLDL (UKB data field 23499)
Free cholesterol in large VLDL (UKB data field 23500)
Triglycerides in large VLDL (UKB data field 23501)
Cholesteryl esters in IDL (UKB data field 23527)
Triglycerides in IDL (UKB data field 23529)
Free cholesterol in IDL (UKB data field 23528)
Cholesterol in IDL (UKB data field 23526)
Cholesteryl esters in very large HDL (UKB data field 23555)
Free cholesterol in very large HDL (UKB data field 23556)
Cholesterol in very large HDL (UKB data field 23554)
Triglycerides in very large HDL (UKB data field 23557)
Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591)
Cholesterol to total lipids in large VLDL percentage (UKB data field 23590)
Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)
Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594)
Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)
Triglycerides to total lipids in large LDL percentage (UKB data field 23618)
Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)
Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621)
Phospholipids to total lipids in medium LDL percentage (UKB data field 23619)
Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616)
Conventional bullous pemphigoid
Hearing problems
Breast area percent density
Multi-trait sex score
Metabolic signature
Multi-trait sum score
Post-traumatic stress disorder
Gastroesophageal reflux disease or bipolar disorder (pleiotropy)
Osteoarthritis
Right hippocampal volume
Ventromedial occipital thickness (unadjusted for global measures)
ICD10 M51: Intervertebral disc disorder
Flt3L levels
IL2RA levels
Addiction risk factors
Cognitive performance (global cognitive function) (longitudinal)
Cognitive performance (memory) (longitudinal)
Cannabis use disorder (MTAG)
Hyper-haemoglobinised percentage of red cells
Macrocytic percentage of red cells
Red blood cell side fluorescence
Red blood cell side fluorescence distribution width
Neutrophil forward scatter distribution width
Coronary artery calcification
Platelet forward scatter distribution width
Delta of the red cell haemoglobins
Reticulocyte production index
Lymphocyte side fluorescence
Metabolite levels (3-hydroxydecanoate)
Metabolite levels (gamma-glutamylthreonine)
Parkinson's disease
Platelet forward scatter
Red cell distribution width - standard deviation
Metabolite levels (1-palmitoylglycerophosphocholine (16:0); 1-palmitoyl-GPC (16:0); C16:0 LPC; C16_0_LPC)
Metabolite levels (pyruvate; cmh_pyruvate; Pyruvate)
Metabolite levels (mannose)
Metabolite levels (threonine)
Neutrophil side fluorescence
Alcohol use disorder (MTAG)
Metabolite levels (alanine)
Metabolite levels (2'-O-methyluridine)
Metabolite levels (1-palmitoyl-2-oleoyl-GPC (16:0/18:1); C34:1 PC; C34_1_PC)
Aging
Bone mineral density mean
Whole body fat free mass (UKB data field 23101)
Current medication use (UKB data field 20003)
Femoral neck width
Body fat percentage (adjusted for testosterone and SHBG)
B-cell lymphoblastic leukemia or rheumatoid arthritis (pleiotropy)
IL6 expression at 6 weeks in whole blood upon Bbmix moi10 stimulation in Lyme borreliosis
Multiple system atrophy
ECG cardiac MRI latent space
25-hydroxyvitamin D levels (skin colour stratified)
25-Hydroxyvitamin D levels
ECG latent space
Myocardial infarction
Cholelithiasis (UKB data field 20002_1162)
Soluble transferrin receptor concentration
Memory decline
Takes medication for lung cancer?
Calcium (minimum, inv-norm transformed)
Baseline memory x sex interaction
Pyruvate levels in blood donors
Lactate levels in blood donors
D-Glucose levels in blood donors
2-phospho-D-glycerate or 3-phospho-D-glycerate levels in blood donors
ATP levels in blood donors
Phosphoenolpyruvate levels in blood donors
D-Hexose-phosphate levels in blood donors
Estimated glomerular filtration rate (creatinine, cystatin c)
Telomere length (principal component 1)
Baseline memory
Baseline memory in normal cognition
Serum levels of protein IGF1
IGF-1 and IGFBP-3 levels (bivariate analysis)
Whole body fat mass (UKB data field 23100)
Age at menarche or uterine leiomyomata (pleiotropy)
Tinnitus
High-sensitivity C-reactive protein levels
Bone mineral density variability
Postmenopausal breast cancer
Hearing difficulty
T1 CAT volume L LateralOccipitalCortexinferiordivision
Serum 25-Hydroxyvitamin D levels (conditioned on BMI)
Serum 25-Hydroxyvitamin D level variance
Serum 25-Hydroxyvitamin D levels x season interaction
Serum 25-Hydroxyvitamin D levels (summer)
neutrophil (fraction, minimum, inv-norm transformed)
Biological Father: Bipolar Disorder
estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed)
estimated glomerular filtration rate (eGFR, mean, inv-norm transformed)
neutrophil (absolute count, maximum, inv-norm transformed)
neutrophil (fraction, mean, inv-norm transformed)
creatinine (maximum, inv-norm transformed)
CAMSIS occupational score (MTAG)
estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed)
Takes medication for Thyroid problems?
Cranial vault shape (segment 8)
Random glucose levels
Color vision defects (Deutan-Protan)
Uric acid levels (1KG-JEWEL7K)
Total cholesterol levels (1KG-JEWEL7K)
Waist-hip index
Hip index
Serum creatinine levels
Diacylglycerol_44:7_[M+H-H2O]1+ levels
Lysophosphatidylethanolamine_16:0_[M-H]1- levels
Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels
Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels
Phosphatidylcholine-O_30:1_[M+H]1+/Phosphatidylcholine-P_30:0_[M+H]1+/Phosphatidylethanolamine-O_33:1_[M+H]1+ levels
Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels
Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels
Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels
Diacylglycerol_32:2_[M+H-H2O]1+ levels
Diacylglycerol_34:1_[M+H-H2O]1+ levels
Diacylglycerol_34:3_[M+H-H2O]1+ levels
Diacylglycerol_34:2_[M+H-H2O]1+ levels
Phosphatidylcholine-2O_32:0_[M+H]1+ levels
Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels
Phosphatidylcholine-O_36:3_[M+H]1+/Phosphatidylcholine-P_36:2_[M+H]1+ levels
Phosphatidylethanolamine_34:1_[M-H]1- levels
A body shape index
Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel
Retinal vascular fractal density
FVC or gastro-oesophageal reflux disease (pleiotropy)
FEV1 or gastro-oesophageal reflux disease (pleiotropy)
Gamma glutamyl transpeptidase
Weight
Goiter
Hearing loss, difficulty in hearing
Spinal canal stenosis
Cholecystitis
Cholelithiasis
Atrial fibrillation/atrial flutter
Angina pectoris
Uterine prolapse
Triacylglycerol_50:2_[M+NH4]1+ levels
Triacylglycerol_50:3_[M+NH4]1+ levels
Triacylglycerol_50:4_[M+NH4]1+ levels
Triacylglycerol_50:5_[M+NH4]1+ levels
Triacylglycerol_52:6_[M+NH4]1+ levels
Sphingomyelin_34:1_[M+H]1+ levels
Sphingomyelin_33:1_[M+H]1+ levels
Sphingomyelin_34:0_[M+H]1+ levels
Sphingomyelin_34:2_[M+H]1+ levels
Sphingomyelin(33:1)_[M-CH3]1- levels
Sphingomyelin_35:1_[M+H]1+ levels
Sphingomyelin(37:1)_[M+H]1+ levels
